Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
B- cell lymphoma
Jun 14, 2024, 02:22 |
Opinion
Harshal Chorya: Dr. Sam Yamshon captivating keynote on B-Cell Lymphomas
Harshal Chorya, HealthCare Professional at Baroda Medical College, shared a post on X: "Breakthrough Alert!…
May 29, 2024, 13:46 |
Blog
Harshal Chorya: Upcoming keynote presentation by Dr. Samuel Yamshon on "Strategies to Improve CAR T Cell Fitness in B-Cell Lymphomas”
Harshal Chorya, HealthCare Professional at Baroda Medical College, shared a post on LinkedIn: “We are…
Apr 21, 2024, 18:36 |
Blog
Talha Badar: Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity
Talha Badar, Assistant Professor of Oncology at Mayo Clinic, shared a post on X: “Real-World…
Feb 12, 2024, 01:17 |
Insight
Aaron Goodman: Sorting out High Grade B-cell Lymphomas using morphology and FISH!
Aaron Goodman shared a post on X/Twitter: “Sorting out High Grade B-cell Lymphomas using morphology and…
Jan 14, 2024, 17:49 |
Insight
Amar Kelkar: We show Axi-cel and Liso-cel are NOT COST-EFFECTIVE in our decision analysis of second-line CAR-T therapies for Diffuse Large B-Cell Lymphoma
Amar Kelkar, Stem Cell Transplantation Physician at the Dana-Farber Cancer Institute, posted on X/Twitter: "Today in…
Dec 18, 2023, 23:45 |
Blog
Jason Westin: Targeted therapy combinations are safe and effective as an initial treatment for patients with Large B-cell Lymphoma
Jason Westin, Director of Clinical Research and Section Chief of Aggressive Lymphoma at MD Anderson…
Oct 17, 2023, 01:19 |
Drugs
Edward Cliff: POLARIX trial of antibody-drug conjugate polatuzumab vedotin in diffuse large B-cell lymphoma.
Edward Cliff, Postdoctoral Research Fellow at Harvard Medical School, shared on LinkedIn: “Just out in…
Sep 21, 2023, 18:12 |
Insight
Fiona Hamilton Marshall: These are hopeful findings for patients with relapsed/refractory diffuse large B-cell lymphomawho may not have a durable response to existing therapies.
Aug 12, 2023, 16:19 |
Drugs
Aaron Goodman: LOTIS-9 Trial in diffuse large B-cell lymphoma Pauses Enrollment Due to Respiratory Toxicities
In a post on Twitter by Aaron Goodman, Hematologist/Bone Marrow Transplanter at UCSD, it says,…
Jun 18, 2023, 16:32 |
Drugs
FDA approved our new bispecific antibody for treating people with relapsed or refractory Diffuse Large B-cell Lymphoma
In a post by Alexander Hardy on Linkedin, it says, "I’m excited to share that…
1
2
3
4
5
All:
90
Posts:
11 - 20
Dilyara Kaidarova is running for the UICC Board of Directors
Lance Armstrong and Testicular Cancer: Story, Symptoms, Treatment
Honoring Jeff Weber, a giant in the field of oncology
Douglas Flora: The Great Wave off Kanagawa captures my feelings on certain days
Enrique Soto is running for the SIOG Board of Directors
Facebook
RSS Feed
Twitter
Linkedin
Youtube